Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
04-10-02 Nicotine dependence
| Cytisine (Cytisinicline) 1.5mg tablets |
|
Formulary
|
Prescribed only as part of a programme of behavioural support for patients in England through NHS Stop Smoking Services. |
|
| Varenicline Champix® |
|
Formulary
|
Tablets 0.5mg, 1mg Prescribed only as part of a programme of behavioural support for patients in England through NHS Stop Smoking Services. |
 NICE TA123: Varenicline for smoking cessation |
|
Links
LSCMMG: Opioid reduction: best interests opioid reduction position statement- LSCMMG: OpioId treatment: patient-prescriber opioid treatment agreement
- LSCMMG: Restless Legs Syndrome in Adults in Primary Care
- MHRA Drug Safety Update Jan 2020: E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury
- MHRA Drug SAfety Update Nov 2020: Bupropion (Zyban): risk of serotonin syndrome with use with other serotonergic drugs
- MHRA safety update (Nov 2008)
- NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
- NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
- NICE TA123: Varenicline for smoking cessation
- NICE TA123:Varenicline for smoking cessation
UKMI Q&A: Smoking and Drug Interactions